The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Amgen; Art tempi; AstraZeneca; Celgene; Clovis Oncology; Connected Medical Solutions
Consulting or Advisory Role - Amgen; AstraZeneca; Biom'up; Celgene; ClearCut Medical; Clovis Oncology; Daiichi Sankyo
Research Funding - Exact Sciences
Travel, Accommodations, Expenses - Amgen; Art tempi; AstraZeneca; Celgene; Clovis Oncology; Connected Medical Solutions
 
Consulting or Advisory Role - Lilly; Novartis; Pfizer
Travel, Accommodations, Expenses - Celgene; Eisai; Roche
 
Travel, Accommodations, Expenses - Roche
Modulation by treatment of tumor infiltrating lymphocytes (TILs) and PDL1 expression in triple-negative breast cancer in the ETNA trial.
 
Giampaolo Bianchini
Consulting or Advisory Role - Amgen; AstraZeneca; Chugai Pharma; Daiichi Sankyo; Eisai; Genomic Health; Lilly; MSD; NeoPharm; Novartis; Pfizer; Roche; Sanofi
Patents, Royalties, Other Intellectual Property - European Patent Application N. 12195182.6 and 12196177.5’, titled “PDL-1 expression in anti-HER2 therapy
Travel, Accommodations, Expenses - AstraZeneca; Eisai; Pfizer; Roche
 
Chanel Smart
No Relationships to Disclose
 
Mauro Mansutti
No Relationships to Disclose
 
Hans-Joachim Lück
No Relationships to Disclose
 
Stefania Zambelli
No Relationships to Disclose
 
Clara Olier
Speakers' Bureau - Eisai; Novartis; Teva
Travel, Accommodations, Expenses - Novartis; Pfizer
 
Antonio Anton
Consulting or Advisory Role - Bayer
 
Giancarlo Bisagni
No Relationships to Disclose
 
Laura Merlini
Travel, Accommodations, Expenses - Roche
 
Serafin Morales Murillo
No Relationships to Disclose
 
Lourdes Calvo Martínez
No Relationships to Disclose
 
Jose Ignacio Chacon
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Eisai; Merck; Novartis; Pfizer; Pierre Fabre; Roche
Travel, Accommodations, Expenses - Celgene; Roche
 
Vladimir Semiglazov
No Relationships to Disclose
 
Marc Thill
No Relationships to Disclose
 
Arlene Chan
Honoraria - Amgen; Eisai; Novartis
Consulting or Advisory Role - Lilly; Pfizer; Specialised Therapeutics
Speakers' Bureau - Prime Oncology
Research Funding - Eisai
Travel, Accommodations, Expenses - Amgen
 
Ignasi Tusquets
Consulting or Advisory Role - Roche
Speakers' Bureau - Celgene
Research Funding - Roche
Travel, Accommodations, Expenses - Roche
 
Luca Licata
No Relationships to Disclose
 
Pinuccia Valagussa
No Relationships to Disclose
 
Giuseppe Viale
Honoraria - MSD Oncology; Pfizer
Consulting or Advisory Role - Astellas Pharma; Bayer; Daiichi Sankyo; Dako; Menarini; MSD Oncology; Novartis; Roche/Genentech
Speakers' Bureau - Roche/Genentech
Research Funding - Cepheid (Inst); Dako/Agilent Technologies (Inst); Roche/Genentech; Ventana Medical Systems (Inst)
Travel, Accommodations, Expenses - Celgene; Roche
 
Luca Gianni
Consulting or Advisory Role - ADC Therapeutics; AstraZeneca; Celgene; Daiichi Sankyo; Forty Seven; G1 Therapeutics; Genenta Science; Genentech; Genomic Health; Lilly; Merck Sharp & Dohme; METIS Precision Medicine; Novartis; Odonate Therapeutics; Oncolytics; Onkaido Therapeutics; Pfizer; Revolution Medicines; Roche; Sandoz; Seagen; Synaffix; Synthon; Taiho Pharmaceutical; Zymeworks
Research Funding - Celgene (Inst); Revolution Medicines (Inst); Zymeworks (Inst)
Patents, Royalties, Other Intellectual Property - Roche
Travel, Accommodations, Expenses - Celgene; Chugai Pharma; Pfizer; Roche